Botulinum Toxin for Urinary Tract Disease: After a Decade from Approval

Prijzen vanaf
66,99

Uitgelicht

VERGELIJK ALLE AANBIEDERS (2)

Beschrijving

Bol Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector?

Vergelijk aanbieders (2)

Sorteren op:

€ 66,99 Gratis verzending

€ 71,30 Gratis verzending

Beschrijving (1)

Botulinum toxin was approved by the Food and Drug Administration in 2011 for neurogenic bladder and in 2013 for idiopathic overactive bladder (OAB). In this Special Issue, we address the question of where we stand with this therapy a decade later. Has it prevailed and been proven useful? Which techniques have become established, and how were they optimized? Are more practical ways of distribution on the way? What acceptance problems or obstacles to long-term use might exist among patients or doctors? What are the risks? Has the therapy gained a foothold in the outpatient sector?


Productspecificaties

Merk MDPI AG
EAN
  • 9783725863389
Maat


Prijshistorie

* Prijshistorie bevat geen data van Amazon.

Prijzen voor het laatst bijgewerkt op:

Uitgelichte Keuze
66,99
Naar shop